Initial p53 mutations are crucial in the “chronic inflammation-dysplasia-cancer” pathway of carcinogenesis, which is closely related to the development of colitis-associated colorectal carcinoma (CAC) in the context of inflammatory bowel disease (IBD). Here, TP53 is linked to inflammatory bowel disease.